Expression of α‐SMA at invasive tumour front but not tumour centre had prognostic value for patient survival, pinpointing the importance of assessing the invasive tumour front when evaluating the potential of various stromal molecules as prognostic biomarkers. The gene discussed is ACTA1; the disease is neoplasm.